$ADVB News

Advanced Biomed Q3 EPS $(0.38) Up From $(1.17) YoY

Why Advanced Biomed Shares Are Cooling Off Wednesday?

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Advanced Biomed Inc. Announces 1 for 20 Share Consolidation

Advanced Biomed shares are trading lower after the company announced a 1-for-20 share consolidation.

Advanced Biomed Announces 1-For-20 Share Consolidation, Effective February 20

Advanced Biomed Q2 EPS $0.32

Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery

Advanced Biomed Inks Clinical Research Collaboration Agreement With Chi‑Mei Medical Center To Start 120-Case Feasibility Trial To Access Predictive Accuracy Of A+PerfusC 3D Cell Culture

12 Health Care Stocks Moving In Thursday's After-Market Session

Advanced Biomed sells Hong Kong subsidiary for $23,000

Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary

Advanced Biomed Signs Agreement On Dec. 23 With Wei Ha Hui To Sell Its Hong Kong Subsidiary For $23K

Advanced Biomed Q1 EPS $(0.02) Down From $(0.01) YoY

Advanced Biomed Q4 EPS $(0.03) Up From $(0.04) YoY

Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery

Advanced Biomed Launches A+PerfusC System Designed To Replicate Human Physiological Conditions In Vitro